(Q35681560)
Statements
1 reference
Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC. (English)
1 reference
C M Rocha Lima
1 reference
N A Rizvi
1 reference
C Zhang
1 reference
J E Herndon
1 reference
J Crawford
1 reference
R Govindan
1 reference
G W King
1 reference
M R Green
1 reference
Cancer Leukemia Group B
1 reference
1 reference
Identifiers
1 reference